Open Access
Safety and efficacy of compound edaravone versus edaravone for patients with acute ischaemic stroke: a phase II, multicentre, randomised, double-blind, multiple-dose, active-controlled clinical trial
Jie Xu, Yilong Wang, Anxin Wang, Zhiqiang Gao, Xiaoping Gao, Huisheng Chen, Junshan Zhou, Xingquan Zhao, Yongjun Wang
DOI: 10.1136/svn-2018-000221 Published 22 April 2019
Jie Xu
1Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China
2China National Clinical Research Center for Neurological Diseases, Beijing, China
Yilong Wang
1Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China
2China National Clinical Research Center for Neurological Diseases, Beijing, China
Anxin Wang
1Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China
2China National Clinical Research Center for Neurological Diseases, Beijing, China
Zhiqiang Gao
3Department of Neurology, The Second Affiliated Hospital of Nanjing Medical University, Nanjing, China
Xiaoping Gao
4Department of Neurology, The First Affiliated Hospital of Hunan Normal University, Changsha, China
Huisheng Chen
5Department of Neurology, General Hospital, PLA Shenyang Military Region, Shenyang, China
Junshan Zhou
6Department of Neurology, Nanjing First Hospital, Nanjing Medical University, Nanjing, China
Xingquan Zhao
1Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China
2China National Clinical Research Center for Neurological Diseases, Beijing, China
Yongjun Wang
1Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China
2China National Clinical Research Center for Neurological Diseases, Beijing, China

No eLetters have been published for this article.
Safety and efficacy of compound edaravone versus edaravone for patients with acute ischaemic stroke: a phase II, multicentre, randomised, double-blind, multiple-dose, active-controlled clinical trial
Jie Xu, Yilong Wang, Anxin Wang, Zhiqiang Gao, Xiaoping Gao, Huisheng Chen, Junshan Zhou, Xingquan Zhao, Yongjun Wang
Stroke and Vascular Neurology Apr 2019, svn-2018-000221; DOI: 10.1136/svn-2018-000221

Safety and efficacy of compound edaravone versus edaravone for patients with acute ischaemic stroke: a phase II, multicentre, randomised, double-blind, multiple-dose, active-controlled clinical trial
Jie Xu, Yilong Wang, Anxin Wang, Zhiqiang Gao, Xiaoping Gao, Huisheng Chen, Junshan Zhou, Xingquan Zhao, Yongjun Wang
Stroke and Vascular Neurology Apr 2019, svn-2018-000221; DOI: 10.1136/svn-2018-000221
Safety and efficacy of compound edaravone versus edaravone for patients with acute ischaemic stroke: a phase II, multicentre, randomised, double-blind, multiple-dose, active-controlled clinical trial
Jie Xu, Yilong Wang, Anxin Wang, Zhiqiang Gao, Xiaoping Gao, Huisheng Chen, Junshan Zhou, Xingquan Zhao, Yongjun Wang
Stroke and Vascular Neurology Apr 2019, svn-2018-000221; DOI: 10.1136/svn-2018-000221